Window of opportunity for daclizumab

Kimberly S. Schluns

doi:10.1038/nm0511-545

Window of opportunity for daclizumab

Kimberly S. Schluns

Immunology

Research output: Contribution to journal › Comment/debate › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	545-547
Number of pages	3
Journal	Nature medicine
Volume	17
Issue number	5
DOIs	https://doi.org/10.1038/nm0511-545
State	Published - May 2011

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/nm0511-545

Cite this

@article{2cddd3131b2e4b0f9eee079aa202e325,

title = "Window of opportunity for daclizumab",

author = "Schluns, {Kimberly S.}",

year = "2011",

month = may,

doi = "10.1038/nm0511-545",

language = "English (US)",

volume = "17",

pages = "545--547",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Window of opportunity for daclizumab

AU - Schluns, Kimberly S.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79955695969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955695969&partnerID=8YFLogxK

U2 - 10.1038/nm0511-545

DO - 10.1038/nm0511-545

M3 - Comment/debate

C2 - 21546970

AN - SCOPUS:79955695969

SN - 1078-8956

VL - 17

SP - 545

EP - 547

JO - Nature medicine

JF - Nature medicine

IS - 5

ER -

Window of opportunity for daclizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this